Apellis Pharmaceuticals, Inc. (APLS)

40.94 0.00 (0.00%) USD  |  NASDAQ  |  Apr 21, 16:00
40.93 -0.01 (-0.02%) Pre-Market: 09:18
More

Apellis Pharmaceuticals Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Biogen, Inc. Upgrade
Eli Lilly & Co. Upgrade
Agios Pharmaceuticals, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade
Kezar Life Sciences, Inc. Upgrade